Active Ingredient History

  • Now
Zibotentan is an experimental anti-cancer drug candidate in development by AstraZeneca. It is an endothelin receptor antagonist.   Wikipedia

  • SMILES: COc1nc(C)cnc1NS(=O)(=O)c2cccnc2c3ccc(cc3)c4ocnn4
  • Mol. Mass: 424.44
  • ALogP: 2.71
  • ChEMBL Molecule:
More Chemistry
trans,trans-2(4-methoxyphenyl)-4-(1-3-benzodiazol-5-yl)-1-(dibutylaminocarbonylmethyl)pyrrolidine-3-carboxylic acid | zd4054 | zd-4054 | zibotentan


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue